Detecting Growing Mammary Tumors with Monoclonal Antibodies Against Vascular Endothelial Growth Factor Receptor - 3

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|3|1|60-65

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.3, Iss.1, 2010-01, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study

By LoRusso Patricia   Krishnamurthi Smitha   Youssoufian Hagop   Hall Nancy   Fox Floyd   Dontabhaktuni Aruna   Grebennik Dmitri   Remick Scot  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 303-311

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 275-287

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies

By  

Current Medicinal Chemistry, Vol. 16, Iss. 29, 2009-01 ,pp. : 3797-3804

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 257-268

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite